NierajJainMD

Ophthalmology • Atlanta, GA

Physician

Join to view full profile

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jain's full profile

Already have an account?

Office
1365 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-778-2020

Fax+1 404-778-5059

Education & Training

Duke University HospitalResidency, Ophthalmology, 2008 - 2011
University of Rochester Medical CenterResidency, Internal Medicine, 2007 - 2008
Duke University School of MedicineClass of 2007

Certifications & Licensure

OR State Medical License 2014 - Present
GA State Medical License 2014 - 2026
MI State Medical License 2012 - 2016
NC State Medical License 2008 - 2015
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Reply to Comment on "Pentosan Polysulfate Maculopathy: Final Outcomes from a 4-Year Prospective Study of Disease Progression after Drug Cessation".
Brian P Hall, Sakshi Shiromani, Emily H Jung, Riley J Lyons, Judith Tribe
American Journal of Ophthalmology. 2025-03-11
Pentosan Polysulfate Maculopathy: Final Outcomes from a 4-Year Prospective Study of Disease Progression after Drug Cessation.
Brian P Hall, Sakshi Shiromani, Emily H Jung, Riley J Lyons, Judith Tribe
American Journal of Ophthalmology. 2025-03-01
Reduced retinal microvascular density in women with coronary microvascular dysfunction: A pilot study.
Sakshi Shiromani, Ahmed AlBadri, Aaron Lindeke-Myers, Arielle Schwartz, Nishant Vatsa
American Heart Journal Plus. 2025-03-01

Journal Articles

Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug Cessation
Joseph M Simonett, Mark E Pennesi, Nieraj Jain, JAMA Ophthalmology

Authored Content

Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020
Disease Course in Patients with Pentosan Polysulfate Sodium–Associated Maculopathy After Drug CessationJuly 2020

Press Mentions

Treatment for Stargardt Disease May Be CloseJanuary 21st, 2025
FDA Approves Light Therapy for Dry AMDJanuary 21st, 2025
Presumed Rubber Bullet Ocular TraumaJuly 3rd, 2020
Join now to see all